Exploring 3 High Growth Tech Stocks in US Market

Cloudflare

Cloudflare

NET

0.00

Over the last 7 days, the United States market has experienced a 2.1% drop, yet it shows resilience with a 19% rise over the past year and an annual earnings growth forecast of 17%. In this context, identifying high-growth tech stocks involves looking for companies that not only align with these positive growth trends but also demonstrate strong potential to capitalize on technological advancements and market opportunities.

Top 10 High Growth Tech Companies In The United States

Name Revenue Growth Earnings Growth Growth Rating
Fabrinet 21.13% 21.40% ★★★★★★
Coherent 30.36% 43.92% ★★★★★★
TG Therapeutics 21.54% 21.27% ★★★★★★
Lumentum Holdings 40.65% 104.45% ★★★★★★
AnaptysBio 20.47% 48.14% ★★★★★★
Insmed 32.21% 67.01% ★★★★★★
Madrigal Pharmaceuticals 27.97% 63.67% ★★★★★★
Syndax Pharmaceuticals 29.25% 69.45% ★★★★★★
Travere Therapeutics 24.31% 53.11% ★★★★★★
Precigen 34.82% 55.42% ★★★★★★

Underneath we present a selection of stocks filtered out by our screen.

Flex (FLEX)

Simply Wall St Growth Rating: ★★★★★★

Overview: Flex Ltd. offers technology innovation, supply chain, and manufacturing solutions across various industries including data center, communications, enterprise, consumer, automotive, healthcare, industrial, and power sectors in the Americas, Asia, and Europe with a market capitalization of approximately $40.76 billion.

Operations: Flex Ltd. generates revenue through three primary segments: Cloud and Power Infrastructure ($7.19 billion), Integrated Technology Solutions ($11.61 billion), and Regulated Manufacturing Solutions ($10.47 billion).

Flex Ltd. recently showcased robust growth, revising its fiscal 2027 earnings guidance upwards with expected net sales hitting between $33.7 billion and $35.2 billion, marking a 23% increase at the midpoint over previous forecasts. This adjustment follows a strong first quarter where net sales surged to $7.93 billion from $6.58 billion year-over-year, coupled with net income climbing to $285 million from $192 million. The company's strategic expansion in AI technology manufacturing—particularly through scaling up production of the Cerebras CS-3 system—is set to enhance its high-tech manufacturing capabilities significantly, anticipating a sevenfold increase in production capacity by enhancing infrastructure and integrating advanced technologies at their Milpitas facility. These developments not only underscore Flex’s proactive strides in innovation but also highlight its potential to capitalize on increasing demands within the AI sector, positioning it as a noteworthy contender in the high-growth tech landscape despite recent drops from several Russell indexes.

FLEX Revenue and Expenses Breakdown as at Aug 2026
FLEX Revenue and Expenses Breakdown as at Aug 2026

Ionis Pharmaceuticals (IONS)

Simply Wall St Growth Rating: ★★★★★★

Overview: Ionis Pharmaceuticals, Inc. is a commercial-stage biotechnology company specializing in RNA-targeted medicines in the United States, with a market cap of approximately $9.76 billion.

Operations: Ionis Pharmaceuticals generates revenue primarily from its Ionis Operations segment, totaling $874.09 million. The company focuses on developing RNA-targeted medicines.

Ionis Pharmaceuticals, recently spotlighted at the ESC Congress 2026, is making significant strides in severe hypertriglyceridemia (sHTG) management with its FDA-approved drug TRYNGOLZA and investigational siRNA ION775. This focus on innovative RNA-targeted therapies underlines Ionis's commitment to addressing unmet medical needs in lipid disorders—a market with substantial patient impact. With a projected revenue between $875 million and $900 million for 2026, Ionis is leveraging its R&D to potentially transform treatment paradigms in lipid management, aligning with broader industry trends towards targeted molecular therapies.

IONS Earnings and Revenue Growth as at Aug 2026
IONS Earnings and Revenue Growth as at Aug 2026

Cloudflare (NET)

Simply Wall St Growth Rating: ★★★★★★

Overview: Cloudflare, Inc. is a cloud services provider offering various solutions to businesses globally, with a market cap of $103.93 billion.

Operations: The company generates revenue through its Internet Telephone segment, contributing $2.51 billion.

Cloudflare's strategic initiatives, such as becoming an independent Key Transparency auditor for Signal and launching products like Cloudflare OS, underscore its commitment to enhancing secure communications and operational efficiency across the global network. With a recent fixed-income offering raising $2.175 billion, Cloudflare is bolstering its financial position to support these expansive projects. Despite reporting a widened net loss of $192.91 million in the first half of 2026, Cloudflare forecasts robust revenue growth with expectations reaching up to $2.87 billion by year-end, reflecting a significant annual increase from previous figures. This trajectory highlights Cloudflare’s resilience and adaptability in navigating the competitive tech landscape while investing heavily in innovation ($1.335 billion in R&D expenses), which is critical for sustaining long-term growth and securing its position as a pivotal player in internet security and performance solutions.

NET Revenue and Expenses Breakdown as at Aug 2026
NET Revenue and Expenses Breakdown as at Aug 2026

Summing It All Up

  • Take a closer look at our US High Growth Tech and AI Stocks list of 21 companies by clicking here.
  • Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
  • Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.

Searching for a Fresh Perspective?

  • Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
  • Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
  • Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.